• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓性血小板减少性紫癜

Thrombotic thrombocytopenic purpura.

作者信息

Lian E C

机构信息

Division of Hematology, Veterans Administration Medical Center, Miami, Florida.

出版信息

Annu Rev Med. 1988;39:203-12. doi: 10.1146/annurev.me.39.020188.001223.

DOI:10.1146/annurev.me.39.020188.001223
PMID:3285772
Abstract

Platelet thrombus formation in small vessels is triggered by certain stimuli, including vascular injury, primary platelet agglutination, or both. The formation and dissolution of platelet thrombi is modulated by proteolysis, plasma factors, PGI2 synthesis and stability, and immune mechanisms. Some recent evidence now suggests that there is a subset of thrombotic thrombocytopenic purpura (TTP) patients possessing a specific platelet agglutinating factor that triggers the intravascular platelet agglutination. Identification and classification of TTP patients into subgroups with common triggering agents, and further clarification of the role of modifying factors will enable us to understand the disease better and to improve therapy.

摘要

小血管中血小板血栓的形成由某些刺激引发,包括血管损伤、原发性血小板凝集或两者皆有。血小板血栓的形成和溶解受蛋白水解、血浆因子、前列环素(PGI2)合成与稳定性以及免疫机制的调节。最近的一些证据表明,有一部分血栓性血小板减少性紫癜(TTP)患者拥有一种特定的血小板凝集因子,可触发血管内血小板凝集。将TTP患者识别并分类为具有共同触发因素的亚组,并进一步阐明调节因素的作用,将使我们能更好地理解该疾病并改善治疗。

相似文献

1
Thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜
Annu Rev Med. 1988;39:203-12. doi: 10.1146/annurev.me.39.020188.001223.
2
Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.血栓性血小板减少性紫癜——一种由多种致病机制引起的综合征。
Invest Clin. 2001 May;42 Suppl 1:75-86.
3
Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.血栓性血小板减少性紫癜与溶血尿毒综合征:发病机制与治疗的演变概念
Clin Haematol. 1986 May;15(2):413-42.
4
Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.来自血栓性血小板减少性紫癜血浆的新型血小板凝集蛋白。
J Clin Invest. 1985 Oct;76(4):1330-7. doi: 10.1172/JCI112107.
5
The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的血小板聚集因子
Prog Clin Biol Res. 1990;337:141-9.
6
Thrombotic thrombocytopenic purpura: successful treatment unlocks etiologic secrets.血栓性血小板减少性紫癜:成功治疗揭开病因之谜。
Mayo Clin Proc. 1989 Aug;64(8):956-61. doi: 10.1016/s0025-6196(12)61223-3.
7
[Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].[来自一名血栓性血小板减少性紫癜患者血浆的血小板聚集蛋白(PAP)的纯化及某些特性]
Zhonghua Yi Xue Za Zhi. 1989 Jul;69(7):382-4, 28.
8
Studies of the pathogenesis and management of thrombotic thrombocytopenic purpura.
Pol J Pharmacol. 1996 Mar-Apr;48(2):179-84.
9
Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.正常成人免疫球蛋白G对血栓性血小板减少性紫癜血浆中血小板聚集活性的抑制作用。
J Clin Invest. 1984 Feb;73(2):548-55. doi: 10.1172/JCI111242.
10
[Prostacyclin stability in thrombotic thrombocytopenic purpura. Japan Working Group on TTP].[血栓性血小板减少性紫癜中前列环素的稳定性。日本血栓性血小板减少性紫癜工作组]
Nihon Rinsho. 1993 Jan;51(1):142-5.

引用本文的文献

1
Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025.血栓性血小板减少性紫癜:2025年的早期诊断与有效治疗
Intensive Care Med. 2025 Jul 3. doi: 10.1007/s00134-025-07981-3.
2
Seizures in a patient with diffuse scleroderma.弥漫性硬皮病患者的癫痫发作。
Postgrad Med J. 1995 Nov;71(841):687-9. doi: 10.1136/pgmj.71.841.687.